Targeted ablations of genes and analysis of animal models is the classical strategy for enrolling specific retinal gene function. However, transgenic, retina-specific or conditional knockout mouse models often display early lethality or suffer from severe malformations, preventing an analysis beyond embryonic or early postnatal stages.
2. To remove the outer eye layers, in postnatal stages and adult eyes the optic nerve has to be cut off by the help of spring scissors or pinched off by forceps as close to the basis as possible. 3. Turn the eye, so that the back side with the hole where the optic nerve originally resided is facing you. Enter the subretinal space between retina and pigment epithelium with the tips of two very fine forceps from the site where the optic nerve penetrated the eye layers. Note: Usually, the pigment epithelium can be easily identified by its dark colour. In some mouse mutant strains -especially in albino animalsthis pigment layer may however, not be coloured and thus may not be readily to detect. 4. Remove the pigment epithelium with the attached choroid membrane and sclera by carefully tearing to either side with both forceps. 5. Peel off the layers up to the level of the cornea, then turn the eye cup to the lens side and remove the cornea together with pigment epithelium, choroid membrane and sclera, while holding up the remaining retinal cup by the other forceps. 6. Grasp the vitreous together with the small lens and while tearing with forceps, keep the retinal wholemount in place with the second forceps.
Note: When dissecting embryonic eyes, make sure to completely remove the triangular, tent-like capillary plexus underneath the vitreous body together with the vitreous. In the adult eye, the vitreous needs to be grasped at the sides and care has to be taken not to pierce the vitreous with the tips of the forceps as its content is viscous and sticks to the forceps, hindering its removal. 7. For organotypic wholemount culture the retinal cups are collected in a 96-well plate containing 200 μl Dulbecco's modified eagle's medium (see below).
1. Prepare 500 ml culture by weighting 7.8g Dulbecco's modified eagle's medium / nutrient mixture F-12 HAM (DMEM) and 0.6g NAHCO3 and dissolving both in MiIliQ water. Adjust the pH to 7.15. Add 50mg apo-transferin, 50μl putrescin (stock: 60mg/ml), 50μl sodium selenite (stock: 52μg/ml), progesterone (stock: 60μg/ml), and 2.5 ml gentamicine (200 mM) under the hood. Mix and filter through a bottle top filter. Immediately before usage add 10μl glutamine (200 mM) per ml culture medium. Note: This serum-and insulin-free medium can be stored at 4°C for up to 2 weeks and used for apoptosis induction experiments as no insulin counteracts the effects. If incubation of wholemounts for longer than 24h is desired and cell death rates will not be evaluated, insulin serum (e.g. fetal calf serum; FCS) or supplements should be added to improve survival rates. 2. Before starting the culture, the retinal wholemounts are pre-incubated for 15 min at 37°C with 200 μl warm, pH-balanced DMEM containing 0.5mg/ml hyaluronidase to pre-digest the hyaluronidase containing inner and outer limiting membrane of M ller glia cells, facilitating penetration of exogenously applied substances. 3. Retinas are transferred to a 24-well plate with as few hyaluronidase as possible and cultured as organotypic wholemounts in 2ml chemically defined Dulbecco's modified eagle medium. Note: For transferring the retinas, use a 1ml pipette and cut the pipette tip a few millimetres to widen the opening. For embryonic eyes, a 200 μl pipette tip is sufficient. The cutting edges should be smoothened by insertion and twisting of a second pipette tip. For 24-48 hrs short-term cultures, all steps can be performed at the bench, but if contamination of the cultures turns out to be a problem, one should work under the hood. 4. Cultures are maintained for 24 -48 hrs at 37°C in a 5% CO2 atmosphere and e.g. subjected to pharmacological treatment with recombinant factors.
